News Formal

US FDA approves AstraZeneca-Amgen drug for severe asthma

  • 📰 ChannelNewsAsia
  • ⏱ Reading Time:
  • 20 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 11%
  • Publisher: 66%

Business Business Headlines News

Business Business Latest News,Business Business Headlines

The US Food and Drug Administration approved AstraZeneca and Amgen\u0027s drug, Tezspire, to treat severe asthma for those aged 12 years and older, the companies said on Friday (Dec 17). The approval is based on late-stage trial data that showed the drug cut the rate of asthma attacks by 56 per cent

The US Food and Drug Administration approved AstraZeneca and Amgen's drug, Tezspire, to treat severe asthma for those aged 12 years and older, the companies said on Friday .

Amgen, which leads the manufacturing of the drug developed by AstraZeneca, told Reuters it was working to make Tezspire available to patients in January. The drug in the trial had shown promise for wider use against different triggers and is the first and only biologic for severe asthma that does not have an eosinophilic or biomarker limitation within its approved label.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 6. in BUSİNESS

Business Business Latest News, Business Business Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

AMC says over a million people watch new 'Spider-Man' movie at its US theatersAMC Entertainment Holdings Inc said on Friday nearly 1.1 million people watched 'Spider-Man: No Way Home' in its theaters in the United States, a record December opening for a movie across the company's theaters.'Spider-Man: No Way Home', produced by Sony Corp's movie studio and Walt Disney Co, stars Tom
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »